RGNX

REGENXBIO (RGNX)

REGENXBIO Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:RGNX

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/17	06:06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RGNX	REGENXBIO Inc
2024/05/15	05:22	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:RGNX	REGENXBIO Inc
2024/05/10	20:05	PR Newswire (US)	REGENXBIO to Participate in Upcoming Investor Conferences	NASDAQ:RGNX	REGENXBIO Inc
2024/05/09	05:16	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:RGNX	REGENXBIO Inc
2024/05/09	05:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RGNX	REGENXBIO Inc
2024/05/09	05:05	PR Newswire (US)	REGENXBIO Reports First Quarter 2024 Financial Results and Recent Operational Highlights	NASDAQ:RGNX	REGENXBIO Inc
2024/05/01	20:05	PR Newswire (US)	REGENXBIO to Host Conference Call on May 8 to Discuss First Quarter 2024 Financial Results and Recent Operational Highlights	NASDAQ:RGNX	REGENXBIO Inc
2024/04/24	20:05	PR Newswire (US)	REGENXBIO to Participate in Chardan's 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit	NASDAQ:RGNX	REGENXBIO Inc
2024/03/28	20:05	PR Newswire (US)	REGENXBIO Announces Lancet Publication of Phase I/IIa Study Evaluating ABBV-RGX-314 as a One-Time Gene Therapy for Wet AMD	NASDAQ:RGNX	REGENXBIO Inc
2024/03/28	05:05	PR Newswire (US)	REGENXBIO to Participate in Cantor Fitzgerald's Virtual DMD and Other Dystrophy Days	NASDAQ:RGNX	REGENXBIO Inc
2024/03/11	21:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RGNX	REGENXBIO Inc
2024/03/11	20:05	PR Newswire (US)	REGENXBIO to Participate in Upcoming Investor Conferences	NASDAQ:RGNX	REGENXBIO Inc
2024/03/08	20:09	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:RGNX	REGENXBIO Inc
2024/03/08	08:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RGNX	REGENXBIO Inc
2024/03/07	20:03	Edgar (US Regulatory)	Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses	NASDAQ:RGNX	REGENXBIO Inc
2024/03/07	13:20	PR Newswire (US)	REGENXBIO Announces Pricing of Upsized Public Offering of Common Stock and Pre-funded Warrants	NASDAQ:RGNX	REGENXBIO Inc
2024/03/07	06:23	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:RGNX	REGENXBIO Inc
2024/03/07	06:10	PR Newswire (US)	REGENXBIO Announces Proposed Public Offering of Common Stock	NASDAQ:RGNX	REGENXBIO Inc
2024/03/06	06:26	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:RGNX	REGENXBIO Inc
2024/03/05	21:05	PR Newswire (US)	REGENXBIO ANNOUNCES NEW POSITIVE INITIAL EFFICACY DATA FROM AFFINITY DUCHENNE® TRIAL	NASDAQ:RGNX	REGENXBIO Inc
2024/03/01	06:57	PR Newswire (US)	REGENXBIO to Host Webcast Event to Discuss New Interim Clinical Data from the Phase I/II AFFINITY DUCHENNE® Trial	NASDAQ:RGNX	REGENXBIO Inc
2024/02/28	06:54	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:RGNX	REGENXBIO Inc
2024/02/28	06:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RGNX	REGENXBIO Inc
2024/02/28	06:05	PR Newswire (US)	REGENXBIO Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Operational Highlights	NASDAQ:RGNX	REGENXBIO Inc
2024/02/21	21:05	PR Newswire (US)	REGENXBIO to Host Conference Call on February 27 to Discuss Fourth Quarter and Full Year 2023 Financial Results and Recent Operational Highlights	NASDAQ:RGNX	REGENXBIO Inc
2024/02/17	08:28	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RGNX	REGENXBIO Inc
2024/02/08	01:40	PR Newswire (US)	REGENXBIO Announces Pivotal Trial of RGX-121 for the Treatment of MPS II Achieves Primary Endpoint	NASDAQ:RGNX	REGENXBIO Inc
2024/02/07	21:05	PR Newswire (US)	REGENXBIO Announces Completion of Enrollment in Cohort 2 and Additional Positive Interim Data in AFFINITY DUCHENNE® Trial	NASDAQ:RGNX	REGENXBIO Inc
2024/01/31	21:05	PR Newswire (US)	REGENXBIO Announces Presentations at the 20th Annual WORLDSymposium 2024	NASDAQ:RGNX	REGENXBIO Inc
2024/01/19	08:39	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RGNX	REGENXBIO Inc